White Matter Abnormalities and Cognition in Aging and Alzheimer Disease.
Peter C, Sathe A, Shashikumar N, Pechman KR, Workmeister AW, Jackson TB, Huo Y, Mukherjee S, Mez J, Dumitrescu LC, Gifford KA, Bolton CJ, Gaynor LS, Risacher SL, Beason-Held LL, An Y, Arfanakis K, Erus G, Davatzikos C, Tosun-Turgut D, Habes M, Wang D, Toga AW, Thompson PM, Zhang P, Schilling KG, Albert M, Kukull W, Biber SA, Landman BA, Bendlin BB, Johnson SC, Schneider J, Barnes LL, Bennett DA, Jefferson AL, Resnick SM, Saykin AJ, Crane PK, Cuccaro ML, Hohman TJ, Archer DB; Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC) Analyst Team; Alzheimer’s Disease Neuroimaging Initiative (ADNI), the Biomarkers of Cognitive Decline Among Normal Adults (BIOCARD) Study Team, and the Alzheimer’s Disease Sequencing Project (ADSP); Zaras D, Yang Y, Durant A, Kanakaraj P, Kim ME, Gao C, Newlin NR, Ramadass K, Khairi NM, Li Z, Yao T, Choi SE, Klinedinst B, Lee ML, Scollard P, Trittschuh EH, Sanders EA.
Peter C, et al.
JAMA Neurol. 2025 Jun 9:e251601. doi: 10.1001/jamaneurol.2025.1601. Online ahead of print.
JAMA Neurol. 2025.
PMID: 40513084
Free PMC article.